Validation of clinical and preclinical obesity across global cohorts

A study across four countries suggests that using a combined anthropometric measure—including waist circumference and waist-to-height ratio—is more effective than BMI alone for diagnosing clinical obesity. The research indicates that BMI often misclassifies obesity risk and that clinical obesity is a stronger predictor of mortality.
Why it matters
This research supports a shift in global medical standards, potentially improving how obesity is diagnosed and treated to better reflect actual health risks.
In 2025, a Lancet Commission proposed distinguishing clinical obesity, defined by adiposity-related organ dysfunction, from preclinical obesity, defined by excess adiposity with preserved function, and recommended using anthropometric measures beyond body mass index (BMI) to confirm obesity status 1 . Here we report the comparative performance of this framework versus conventional BMI-based classification using prevalence, incidence and mortality data from 844,108 adults across four cohorts in China, the UK, the USA and Spain. Complementing BMI with waist circumference and waist-to-height ratio data showed that BMI alone overestimated obesity in 1.2–3.1% and underestimated it in 5.2–8.6% of participants across cohorts. The combined anthropometric definition increased overall obesity prevalence by 3.3–7.4% relative to BMI-based classification. Clinical obesity accounted for 22.7–31.3% of total obesity, with an overall population prevalence of 5.6–10.9%.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in